Functional Interaction of Nuclear Domain 10 and Its Components with Cytomegalovirus after Infections: Cross-Species Host Cells versus Native Cells by Cosme, Ruth Cruz et al.
Functional Interaction of Nuclear Domain 10 and Its
Components with Cytomegalovirus after Infections:
Cross-Species Host Cells versus Native Cells
Ruth Cruz Cosme, Francisco Puerta Martı ´nez, Qiyi Tang*
Department of Microbiology/AIDS Research Program, Ponce School of Medicine and Health Sciences, Ponce, Puerto Rico, United States of America
Abstract
Species-specificity is one of the major characteristics of cytomegaloviruses (CMVs) and is the primary reason for the lack of a
mouse model for the direct infection of human CMV (HCMV). It has been determined that CMV cross-species infections are
blocked at the post-entry level by intrinsic cellular defense mechanisms, but few details are known. It is important to explore
how CMVs interact with the subnuclear structure of the cross-species host cell. In our present study, we discovered that
nuclear domain 10 (ND10) of human cells was not disrupted by murine CMV (MCMV) and that the ND10 of mouse cells was
not disrupted by HCMV, although the ND10-disrupting protein, immediate-early protein 1 (IE1), also colocalized with ND10
in cross-species infections. In addition, we found that the UL131-repaired HCMV strain AD169 (vDW215-BADrUL131) can
infect mouse cells to produce immediate-early (IE) and early (E) proteins but that neither DNA replication nor viral particles
were detectable in mouse cells. Unrepaired AD169 can express IE1 only in mouse cells. In both HCMV-infected mouse cells
and MCMV-infected human cells, the knocking-down of ND10 components (PML, Daxx, and SP100) resulted in significantly
increased viral-protein production. Our observations provide evidence to support our hypothesis that ND10 and ND10
components might be important defensive factors against the CMV cross-species infection.
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Introduction
Cytomegaloviruses (CMVs) are a b-subfamily of herpes viruses.
Many types of cells (including fibroblast, epithelial, endothelial,
and hematopoietic cells) are permissive for CMV infection, which
infection results in the production of infectious particles [1], but
CMV infection and replication are limited to a narrow host range
[2,3]. For example, murine CMV (MCMV) can produce viral
particles in both mouse and rat cells, while rat CMV (RCMV)
cannot successfully replicate in mouse cells [4,5]. Similar
observations were also reported for human CMV (HCMV) and
simian CMV (SCMV). SCMV productively infected human and
monkey cells, but HCMV failed to replicate in monkey cells [3].
CMV replication in native host cells is a well-defined sequential
process: entry into cells, immediate-early (IE) and early (E) gene
expression, DNA replication, late gene expression, and viral
production [6]. Blocking any stage will cause the failure of
infection. It has been determined that both CMV cross-species
infections and low MOI (multiplicity of infection) infections in
permissive cells are blocked at the post-entry level by intrinsic
cellular defense mechanisms [3,6], but few details are known.
We and others recently discovered that viruses encode gene
products that counter cellular defenses in human cells, which
preventive action can help MCMV to successfully infect human
cells [7,8]. For instance, we discovered that intrinsic cellular
defense mechanisms are involved in blocking MCMV infection in
human cells and that these mechanisms can be overcome by
HCMV-encoded proteins (such as immediate-early protein 1—
IE1), resulting in successful cross-species infection [7]. The Brune
group discovered that the inhibition of apoptosis by the
overexpression of Bcl-2 and other apoptosis inhibitors caused the
successful replication of MCMV in human cells [8]. However,
very few efforts have attempted to determine how HCMV
replication is blocked in mouse cells other than to observe that
HCMV infection in mouse cells is blocked at the IE stage [3]. The
significance of successfully infecting mouse cells with HCMV is
that doing so would enable the development of an HCMV mouse
model. We are also curious whether any nuclear structure (and its
components) is involved in blocking cytomegalovirus cross-species
infection.
A nuclear structure called ND10 (nuclear domain 10) has been
attracting intense attention from virologists due to the functional
interaction of its components with viruses. Several herpes viruses
(e.g., Herpes simplex virus type-1 [HSV-1], cytomegalovirus
[CMV], and Epstein-bar virus [EBV]) were found to be capable
of disrupting ND10 [9,10,11], and various viral proteins have been
identified as being related to ND10 and ND10 proteins, which
identification has been summarized by Dr. Kalejta and colleagues
[12]. Recently, accumulated evidence showed that major ND10
components (PML, Daxx, and SP100) have negative impacts on
the herpesviruses [13,14,15,16,17,18,19,20,21,22,23,24]. There-
fore, it has been assumed that ND10 defends against herpes viral
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e19187infection, but this assumption is contradicted by the fact that
several DNA viruses replicate DNA and transcribe RNA
predominately at ND10 [25,26].
More recently, the Brune group isolated a naturally acquired
mutant MCMV that was able to replicate rapidly and to high titers
in human retinal pigment epithelial (RPE-1) cells [27]. The
interesting observation that the ability of mutated MCMV to
disrupt ND10 seems to be related to viral production [27] initiated
our investigation on whether the disruption of ND10 might be
related to HCMV infection in mouse cells. In the present study, we
discovered that HCMV infection in mouse cells can express IE
and many early genes and is blocked before DNA replication. In
addition, we show that ND10 colocalizes with IE1 in cross-species
infections but is not dispersed by CMV in such infections (HCMV
in mouse cells and MCMV in human cells) and that ND10
components are involved in blocking viral gene expression in both
MCMV and HCMV cross-species infections.
Materials and Methods
Cells and viruses
The following cell lines were used: NIH3T3 (ATCC), Mrc-5
cells (ATCC), and Ad5 E1A-transformed human epithelial kidney
cell 293 (HEK293, ATCC). Cells were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% fetal
calf serum (FCS) and 1% penicillin-streptomycin (PS). The
MCMV Smith strain was from ATCC. The HCMV Towne and
AD169 strains (ATCC) were kept in our laboratory; the clinical
strains of HCMV included FIX [VIR1814, provided by Dr. Gerna
in Italy [28]] and Toledo [provided by Dr. Zhu in UMDNJ [29]];
the UL131-repaired HCMV AD169 strain (vDW215-BA-
DrUL131) was provided by Dr. Shenk (Princeton University) [29].
RNA interference
In order to knock down the expression of the ND10
components, we transfected plasmids, thereby producing small
interference RNA (siRNA) against each component. All the
siRNA-producing plasmids were bought from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA). The shRNA plasmids are
shown in Table 1. An shRNA plasmid (sc-108060) encoding of a
scrambled shRNA sequence that does not lead to the specific
degradation of any cellular message is used as control. For Western
blot analysis, 100 pmol of siRNA plasmid was used for each well of
a 24-well plate of HEK293 cells or NIH3T3 cells; 24 h after
transfection, cells were super-infected with MCMVIE1/3gfp or
the UL131-repaired AD169 (vDW215-BADrUL131) at an MOI
of 1 for another 24 hours, then the cells were harvested and lysed
for protein detection.
Antibodies
The human and mouse ND10-associated proteins were
recognized using the following antibodies from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA): Monoclonal antibody
(mAb) (PG-M3, sc-966) against human PML, polyclonal antibody
(H-238, sc-5621) against human and mouse PML, polyclonal
antibody against human and mouse Daxx (M-112, sc-7152), and
Table 1. shRNA plasmids used in this study.
Mouse cell Human cell
SP-100 (sc-41033-SH) SP-100 (sc-41032-SH)
PML (sc-36283-SH) PML (sc-36284-SH);
Daxx (sc-35177-SH) Daxx (sc-35178-SH)
doi:10.1371/journal.pone.0019187.t001
Figure 1. Immunofluorescent assay to show IE1 and ND10 in CMV cross-species infection. A–C: After HCMV infection in NIH3T3 cells for
5 hour, cells were stained with anti-PML antibody (rabbit) to show ND10 (in red) (A); anti-IE1 antibody (mouse) was used to show IE1 (in green) (B);
the merged picture is shown in C. D–F: After MCMV infection in Mrc-5 cells for 5 hour, cells were stained with anti-PML antibody (Rabbit) to show
ND10 (in red) (D); anti-IE1 antibody (mouse) was used to show IE1 (in green) (E); the merged picture is shown in F.
doi:10.1371/journal.pone.0019187.g001
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mouse SP100 (M-75, sc-25569). MAb against tubulin came from
Sigma Co. (St. Louis, MO). MAb against MCMV IE1 and M112/
113 (E1) were generously provided by S. Jonjic (Croatia).
Monoclonal antibody against HCMV IE1, mAb810, came from
Millipore (Billerica, MA).
Figure 2. Immunofluorescent assay to show cytomegalovirus infection and ND10. A–C: After MCMV infection in NIH3T3 cells for 24 hours,
cells were stained with anti-PML antibody (rabbit) to show ND10 (in red) (A); anti-IE1 antibody (mouse) was used to show IE1 (in green) (B); the
merged picture is shown in C. D–F: After MCMV infection in Mrc-5 cells for 24 hours, cells were stained with anti-PML antibody (rabbit) to show ND10
(in red) (D); anti-IE1 antibody (mouse) was used to show IE1 (in green) (E); the merged picture is shown in F. G–H: After HCMV infection in NIH3T3
cells for 24 hours, cells were stained with anti-PML antibody (rabbit) to show ND10 (in red) (G); anti-IE1 antibody (mouse) was used to show IE1 (in
green) (H); the merged picture was shown in I. J–L: After HCMV infection in Mrc-5 cells for 24 hours, cells were stained with anti-PML antibody
(rabbit) to show ND10 (in red) (J); anti-IE1 antibody (mouse) was used to show IE1 (in green) (K); the merged picture is shown in L.
doi:10.1371/journal.pone.0019187.g002
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Cells (NIH3T3 or Mrc-5) were infected with HCMV AD169
(vDW215-BADrUL131) at an MOI of 1. Viral DNA was isolated
using the Hirt method [30]. PCR was performed on HCMV DNA
using the following primers: forward-59 GTC AAA CAG ATT
AAG GTT CGA GTG-39 and reverse-59 TTA CTG GTC AGC
CTT GCT TCT AGT 39.
Immunohistochemistry
The localization of ND10 and viral proteins by immunohis-
tochemistry has been described [31]. Briefly, cells were seeded
on coverslips and washed twice with phosphate-buffered saline
(PBS) 24 h later, fixed in 1% paraformaldehyde for 10 min at
room temperature, again washed twice with PBS, and
permeabilized with 0.2% Triton X-100 on ice for 20 min.
Primary antibody was added and incubated for 30 min at room
temperature. Cells were then washed twice with PBS.
Secondary antibody (labeled with Texas Red or fluorescein
isothiocyanate [green] of either anti-rabbit or anti-mouse IgG)
was added and incubated for an additional 30 min at room
temperature. After a final wash with PBS, cells were stained
with Hoechst 33258.
Immunoblot analysis
Proteins were separated by SDS-7.5% polyacrylamide gel
electrophoresis, transferred to nitrocellulose membranes, and
probed according to standard procedures. Membranes were
stripped with stripping buffer (100 mM ß-mercaptoethanol, 2%
SDS, 62.5 mM Tris-HCl, pH 6.8), washed with PBS-0.1% Tween
20, and used to detect additional proteins.
Confocal microscopy
Cells were examined at 1006magnification with a Leica TCS
SPII confocal laser scanning system equipped with a water-cooled
argon-krypton laser. Two wavelength channels (495 and 590 nm)
were recorded simultaneously or sequentially. Power and
integration were adjusted to minimize bleed-through between
the green and far red channels prior to data acquisition. Digital
images obtained were cropped and adjusted for contrast with
Photoshop.
Results
ND10 were not dispersed by cytomegalovirus cross-
species infection but co-localized with the ND10-
disrupting protein (IE1)
At least two aspects of the relationship between ND10 and DNA
viruses have been described: several DNA virus-encoded proteins
colocalize with ND10, and some of them can disperse ND10
[25,32]. The fact that CMV IE1 disrupts the ND10 of native host
cells supports the speculation that ND10 acts in a defensive
capacity. We wondered whether the IE1 of cytomegalovirus could
behave differently in cross-species infections. To determine this,
we performed an immunofluorescence assay to verify whether
CMV IE1 still colocalizes with ND10, such as occurs in the
infection of native host cells [10,26]. As shown in Fig. 1, we stained
Figure 3. Immunofluorescent assay to show IE1 and IE3 in murine cytomegalovirus-infected human and mouse cells. Upper:
MCMVIE1/3gfp-infected NIH3T3 cells to show distribution of IE1 (left) and IE1_IE3 (right). Lower: MCMVIE1/3gfp-infected Mrc-5 cells to show
distribution of IE1 (left) and IE1_IE3 (right).
doi:10.1371/journal.pone.0019187.g003
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D) at five hours post-infection (hpi) of the HCMV UL131-repaired
AD169 (vDW215-BADrUL131) in NIH3T3 cells (A–C) and of the
wt (wild type) MCMV in human cells (D–F). Clearly, at the very
early stage, IE1 presented as patterns of speckles. The IE1 speckles
colocalized with ND10 after CMV cross-species infection in host
cells. Therefore, the distribution of IE1 at the very early stage of
infection was not different in cross-species infection compared with
native infection (e.g., HCMV in human cells and MCMV in
mouse cells).
Next, we performed another IFA to analyze the ability of IE1 to
disperse ND10 in cross-species–infected cells. We infected wt
MCMV into Mrc-5 cells and HCMV into NIH3T3 cells for
24 hours. Cells were fixed and permeabilized and stained with
anti-PML to show ND10 (red, Fig. 2A, D, G, and J) and anti-IE1
to show the distribution of IE1 (green, Fig. 2B, E, H, and K). As
can be seen in HCMV-infected human cells and MCMV-infected
mouse cells, IE1 was diffusely distributed in the nucleus at 24 hpi.
Interestingly, the IE1 of MCMV formed domains (Fig. 2 E) in
human cells and lost the ability to disperse ND10, their
distribution being different from that found in MCMV-infected
mouse cells (Fig. 2 A–C). Similarly, HCMV IE1 also lost the ability
to disperse ND10 in mouse cells (Fig. 2 G–I), which was controlled
by an IFA of the HCMV-infected Mrc-5 cells in which the ND10
was dispersed (Fig. 2 J–L). However, HCMV IE1 did not form
domains in NIH3T3 cells but diffused. The differential distribution
of IE1 and the inability to disperse ND10 in cross-infection might
be related to the failure to induce a productive cytomegalovirus
cross-species infection.
Previously, we discovered that MCMV IE1 and IE3 have no
associations with each other in infected mouse cells [33]. We
wanted to know whether IE1 could be related to IE3 in MCMV-
infected human cells. For the detection of IE3, we infected
NIH3T3 cells with MCMVIE1/3gfp in which IE1 was kept intact
and EGFP was also fused to the C-terminus of IE3 [33]. At 24 hpi,
we performed IFA to stain IE1 red (Fig. 3 A and C) and IE3 green
(Fig. 3B and D). As can be seen, in MCMV1/3gfp-infected mouse
cells, IE1 was shown not to be related to IE3 (Fig. 3A and B),
which is consistent with our previous report [33]. However, IE1
formed domains that colocalized with IE3 domains in MCMV-
infected human cells (Fig. 3C and D). The biological impact of the
association between IE1 and IE3 in MCMV-infected human cells
on viral infection still remains unclear.
Detection of HCMV proteins in infected NIH3T3 cells
Two decades ago, Lafemina and Hayward reported that
HCMV can enter mouse cells and produce only IE1, its infection
being blocked at the IE stage [3]. The strain of HCMV used in
those studies was the Towne strain, which has been attenuated by
serial passage through human fibroblast cells [3]. Recently, it was
discovered that the UL128–131 locus of laboratory strains (Towne
and AD169) has mutated because of their repeated passages
through fibroblast cells, causing the virus to lose its ability to infect
epithelial and endothelial cells [1,29,34,35,36]. Clinical HCMV
strains, or the Ul128–131-repaired AD169 (vDW215-BA-
DrUL131) [29], can infect other types of cells in addition to
fibroblast cells, including endothelial cells, lymphocytes, and
epithelial cells [29,37]. We are curious to know whether either
the clinical or repaired HCMV can replicate in mouse cells or,
alternately, whether it can express more genes in mouse cells than
laboratory strains.
To make this determination, we performed Western blot assays
using different antibodies against viral proteins to detect viral-
protein production in infected cells. Two laboratory stains (AD169
and Towne), one clinical strain (FIX), and Ul128–131-repaired
AD169 (vDW215-BADrUL131) were used to infect either Mrc-5
or NIH3T3 cells for 48 hours, the whole-cell lysates were run on
PAGE gels, and Western blot was performed to detect different
HCMV proteins, as indicated on the right side of Fig. 4A. As can
be seen, the infection of four strains of HCMV can produce all
HCMV proteins (IE, E, and late) as detected in Mrc-5 cells;
however, infection in NIH3T3 cells was blocked at different stages
for different strains. The two laboratory strains (Towne and
AD169) of infection were blocked at the IE stage (only IE1 was
detectable). Repaired AD169 and the clinical strain (FIX) were
blocked at an early stage: several early proteins could be detected,
but late protein was not detectable.
To determine whether HCMV could replicate DNA in
NIH3T3 cells, we infected either Mrc-5 cells or NIH3T3 cells
with repaired AD169; viral DNA was extracted at different times
post-infection by the Hirt method [30]. Then, we performed PCR
using primers to amplify the DNA of HCMV. If the virus could
replicate DNA, the PCR products should show increased amounts
Figure 4. Detection of HCMV proteins and DNA after infection
in NIH3T3 and Mrc-5 cells. A. Western blot assay to detect HCMV
protein production: Whole-cell lysates were prepared at 48 hr after the
infection of different strains of HCMV in MRC-5 cells (left) and NIH3T3
cells (right); after being run on PAGE gels, the proteins were transferred
and detected with specific antibodies. Detected HMCV proteins are
indicated on the right. B. PCR to detect HCMV DNA replication: Using a
modified Hirt method (7), viral DNA was prepared from MRC-5 cells (left)
or NIH3T3 cells (right) at the indicated post-infection times. PCR was
performed using the primers (described in the Material and Methods)
and PCR products were run on an agarose gel in order to visualize the
DNA (using a UV light).
doi:10.1371/journal.pone.0019187.g004
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HCMV-infected Mrc-5 cell shown in Fig. 4 B (left); however, the
DNA level decreased in the HCMV-infected NIH3T3 cells from
48 hpi. Therefore, HCMV cannot replicate DNA in NIH3T3
cells.
Distribution of HCMV proteins in NIH3T3 cells
We observed in the Western blot assay that the repaired
HCMV and the clinical strain of HCMV can produce more IE
and early (E) gene products; we wondered whether the proteins
distribute in these cells as they do in native host cells (human cells).
At 12 hpi, we performed IFA to detect IE2 in NIH3T3 cells. As
shown in Fig. 5A and C, IE2 distributes in the nucleus as speckles,
which is similar to what occurs in native infection. Both UL112/
113 (the homology of to the M112/113 of MCMV) and UL 57
were related to viral DNA replication [33,38] and were produced
before DNA replication. In most cases, both proteins form
domains in the nucleus before DNA replication in human cells.
Here, as can be seen in Fig. 5D and G, the two proteins distributed
in NIH3T3 cell as domains. DAPI was used to show the total cells
(infected and uninfected). Therefore, the repaired HCMV
infection in NIH3T3 cells produced DNA replication-related
early proteins, and those proteins distributed in the nucleus as they
would in cells infected with the native virus.
ND10 proteins are strong suppressors of MCMV infection
in human cells
The most important ND10 proteins include SP100, Daxx,
and PML, all of which have been demonstrated to be intrinsic
defense mechanisms against viral infection. To determine
Figure 5. Immunofluorescent assay to detect HCMV proteins after infection in mouse cells. A–C: Detection of HCMV IE2 in red (A), DAPI
to show total cells (B), and the two merged in C. D–F: Detection of UL112/113 in red (D), DAPI to show total cells (E), and the two merged in F. G–I:
Detection of UL58 in red (G), DAPI to show total cells (H), and the two merged in I.
doi:10.1371/journal.pone.0019187.g005
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MCMV cross-species infection, we used siRNA to knockdown
each protein. One hundred pmol of siRNA was transfected into
HEK293 cells seeded in 24-well plates; siRNA to Luciferase was
u s e da sc o n t r o l .A ss h o w ni nF i g .6 ,2 4 h o u r sa f t e rt h e
t r a n s f e c t i o no fe a c hs i R N Ai n t oH E K 2 9 3c e l l s ,w h o l e - c e l l
lysates were run on PAGE gels, and Western blot assays were
performed to detect PML, Daxx, and SP100. The results
showed that siRNA effectively repressed gene expression as
compared to the loading control protein, tubulin, seen in the
bottom of each slide in Fig. 6.
Twenty-four hours after the transfection of 100 pmol of each
siRNA into the HEK293 cells, the cells were super-infected with
MCMVIE1/3gfp at an MOI of 1; the cells were harvested at
different times post-infection, as indicated, and the whole cell-
lysates were run on PAGE gels, after which different antibodies
were used to ascertain the production of different viral proteins. At
this point, we detected IE1, IE3, and early protein 1 (E1). Tubulin
was used as sample-loading control. Clearly, after knocking down
the ND10 proteins, viral gene products can be increased.
However, knockdown of the ND10 proteins is not enough for
MCMV to productively infect human cells because no viral
particles can be detected in the human cell; some other
mechanism must be involved in blocking the successful infection
of MCMV in human cells.
Knockdown of ND10 proteins enhanced HCMV protein
production in mouse cells
Using siRNA, we also knocked down ND10 proteins (SP100,
Daxx, and PML) from NIH3T3 cells. As shown in Fig. 7, 24 hours
after the transfection of each siRNA into NIH3T3 cells, whole-cell
lysates were run on PAGE gels, and Western blot assays were
performed to detect PML, Daxx, and SP100. The results showed
that siRNA effectively repressed gene expression as compared to
the loading control protein, tubulin, seen in the bottom of each
picture of Fig. 7.
Twenty-four hours after the transfection of 100 pmol of each
s i R N Ai n t oN I H 3 T 3c e l l s ,t h ec e l l sw e r es u p e r - i n f e c t e dw i t ht h e
repaired AD169 at an MOI of 1; the cells were harvested at
different times post-infection, as indicated, and the whole cell-
lysates were run on PAGE gels, after which different antibodies
were used to ascertain the production of different viral proteins.
At this point, we detected IE1 and early proteins UL112/113
and UL57. Tubulin was used as sample-loading control.
Clearly, after knocking down the ND10 proteins, viral gene
products can be increased. However, the essential gene product,
p p 2 8( a l s oc a l l e dt r u el a t ep r o t e in), was not detectable in all
knockdown cells (data not shown). We wondered whether viral
DNA replication can be initiated after knocking down the
inhibitory genes. Using PCR, we also examined DNA
replication in NIH3T3 cells transfected with siRNA against
the respective ND10 components; the results showed there to be
no increase of DNA in those cells following the infection time
course (Fig. 8).
Therefore, ND10 components are important suppressors of
viral gene expression, but the knockdown of ND10 proteins cannot
lead to a productive CMV cross-species infection. There must be
other factors involved in the blocking of HCMV cross-species
infection.
Discussion
In recent years, nuclear domain 10 (ND10), also called PML
bodies, has been a topic of intense interest, especially in terms
of its role in viral infection [13,25]. Although a great deal of
evidence supports the theory that ND10 components such as
PML, Daxx, and SP100 are viral gene repressors and protect
host cells against many viruses [14,16,21,22,26,39,40,41,42],
the effects of the ND10 structure on viral infection have been
not determined. The fact that several herpesviruses are able to
d i s r u p tN D 1 0a tav e r ye a r l ys t a g eo fi n f e c t i o ni m p l i e st h a t
ND10 has a defensive role in the process [9,10,11,26].
However, several DNA viruses (such as herpesviruses) dock
their input DNA, replicate DNA, and transcribe immediate-
early genes at ND10, which argues that ND10 favors viral
replication [10]. To comparatively investigate the roles of
N D 1 0a n dN D 1 0p r o t e i n si nc r o s s - s p e c i e si n f e c t i o n s( M C M V
in human cells and HCMV in mouse cells), we performed an
immunofluorescence assay to detect the effects of CMV
infection on ND10. We discovered that during the infection
of MCMV in human cells, MCMV IE1 distributed both
diffusely and as domains (Fig. 2), which differs from what has
been found in mouse cells, where IE1 distributes only diffusely.
In addition, MCMV IE1 loses the ability to disrupt the ND10
of human cells. HCMV IE1 also loses the ability to disperse
mouse cell ND10.
Previously, it was found that laboratory strains of HCMV
infection in mouse cells can express only IE1 and not IE2, even
though that IE1 shares a promoter and its first three exons with
IE2. Therefore, it was concluded that HCMV infection in mouse
Figure 6. Western blot assay to detect the effects of ND10
proteins (Daxx, PML, and SP100) on MCMV protein produc-
tion. A. siRNA to knockdown the ND10 protein. One hundred pmol of
siRNA (the sequences are shown in Materials and Methods) was
transfected into HEK293 cells for 24 hours, the whole-cell lysates were
run on PAGE gels and probed with antibodies to the targeted proteins,
as indicated. Tubulin was used as a house-keeping gene for sample-
loading control. siRNA-Luc was used as control. B. One hundred pmol of
siRNA was used to transfect HEK293 cells in a 24-well plate; 12 hours
after transfection, the cells were infected with MCMVIE1/3gfp at an MOI
of 1; the cells were harvested at the time indicted, and the whole-cell
lysates were used to detect viral-protein production.
doi:10.1371/journal.pone.0019187.g006
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reported that the laboratory strains of HCMV experience
profound mutations during replication in human fibroblast cells
[29,34,35,36,43]. The mutations lead not only to the attenuation
of HCMV but also to the narrowing of cell tropisms. The
mutation of HCMV cell tropism occurred at gene UL128–131
since the repaired UL128–131 caused the recovery of cell
tropisms [29,34,35,36,43]. Therefore, this time using both the
clinical HCMV strain and the repaired HCMV, we reentered the
study of HCMV infection in mouse cells. At this point, we found
that HCMV could produce IE proteins and some early proteins
(Fig. 4 and 5), but failed to replicate DNA. We now conclude that
HCMV infection in mouse cells was blocked before DNA
replication.
Unlike what takes place in RNA viruses (in which species
specificity is determined by the interaction of viral proteins and
Figure 7. Western blot assay to detect the effects of ND10 proteins (Daxx, PML, and SP100) on HCMV protein production in mouse
cells. A. siRNA to knockdown the ND10 protein. One hundred pmol of siRNA (the sequences are shown in Materials and Methods) was transfected
into NIH3T3 cells for 24 hours, the whole-cell lysates were run on PAGE gels and probed with antibodies to the targeted proteins, as indicated.
Tubulin was used as a house-keeping gene for sample-loading control. siRNA-Luc was used as control. B. One hundred pmol of siRNA was used to
transfect NIH3T3 cells in a 24-well plate; 12 hours after transfection, the cells were infected with repaired AD169 at an MOI of 1, the cells were
harvested at the time indicted, and the whole-cell lysates were used to detect viral-protein production.
doi:10.1371/journal.pone.0019187.g007
Figure 8. Detection of HCMV DNA after infection in NIH3T3 and Mrc-5 cells. siRNA was used to transfect NIH3T3 cells; 12 hours after
transfection, the cells were infected with repaired AD169 at an MOI of 1; using a modified Hirt method (7), viral DNA was prepared from MRC-5 cells
(left) or NIH3T3 cells (right) at the indicated post-infection times. PCR was performed using the primers (described in the Material and Methods) and
PCR products were run on an agarose gel to visualize the DNA (using a UV light).
doi:10.1371/journal.pone.0019187.g008
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o c c u r sn o ta tt h ee n t r yt oc e l l sbut at the post-DNA replication
stage for MCMV infection in human cells [3,45,46,47] and at
the early stage before DNA replication for HCMV infection in
mouse cells. Cellular proteins, including transcription repres-
sors (Daxx, PML, SP100), have suppressive effects on viral
gene expression and represent an intrinsic, host-cell defense
[26,41,48,49]. PML is the scaffold protein and is essential for
the formation of ND10 because PML knockout (k/o) cells lack
ND10, and inducing exogenous PML into PML knockout cells
can restore ND10 [50]. SUMOylation is another characteristic
of PML and makes it possible for PML to interact with many
other nuclear proteins. There are more than 70 different
cellular proteins that have been found to be related to ND10,
and the proteins that interact with PML have already been
reviewed by Dr. Van Ostade1 and colleagues [51]. The most
frequently investigated PML-interacting proteins include Daxx
and SP100. ND10 structure can be shown by indirect
immunofluorescence using anti-PML, -Daxx, and -SP100
antibodies.
The inhibitory effects of ND10 proteins on viral infection have
been demonstrated on PML, Daxx, and SP100. The effects of the
ND10 structure on viral infection have not been determined.
ND10’s defensive role in the infection process can be inferred by
the fact that several herpesviruses are required to disrupt it. We
previously showed that IE1 is the only protein of MCMV that is
capable of disrupting the ND10 of mouse cells [26]. In that prior
study, we reported that the IE1 of MCMV also colocalized with
the ND10 of human cells; however, IE1 lost its ability to disperse
ND10 in cytomegalovirus cross-species infections. This discovery
supports the theory that ND10 might block the productive cross-
species infection of cytomegalovirus. Consistent with this specu-
lation, we found that human-cell ND10 proteins, such as SP100,
PML, and Daxx, strongly suppress MCMV viral gene expression
(Fig. 6), and mouse cell ND10 protein also represses HCMV gene
expression (Fig. 7).
Interestingly, HCMV laboratory-strain infections in mouse cells
can produce IE1 but not IE2, even though IE1 and IE2 share a
promoter and the first three exons, all of which suggests that
splicing regulation also plays a role in blocking HCMV infection in
mouse cells.
In summary, we discovered that intrinsic cellular defense
mechanisms participate in the blocking of CMV cross-species
infection and that CMV IE1 loses its ability to disperse ND10. In
HCMV-infected mouse cells, only IE1 (and not IE2) can be
detected in laboratory-strain–infected mouse cells, but clinical
strains and UL128–131-repaired strains can produce many more
viral gene products. Future studies will focus on identifying the
additional mechanisms that are involved in blocking cross-species
infection.
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